These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25650695)

  • 1. Anti-TNF-α therapy reduces retinol-binding protein 4 serum levels in non-diabetic patients with psoriasis: a 6-month prospective study.
    Pina T; Genre F; Lopez-Mejias R; Armesto S; Ubilla B; Mijares V; Dierssen-Sotos T; Corrales A; Gonzalez-Lopez MA; Gonzalez-Vela MC; Blanco R; Llorca J; Gonzalez-Gay MA
    J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):92-5. PubMed ID: 25650695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of leptin with adiposity and inflammation and resistin with disease severity in psoriatic patients undergoing anti-TNF-alpha therapy.
    Pina T; Genre F; Lopez-Mejias R; Armesto S; Ubilla B; Mijares V; Dierssen-Sotos T; Gonzalez-Lopez MA; Gonzalez-Vela MC; Blanco R; Hernández JL; Llorca J; Gonzalez-Gay MA
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1995-2001. PubMed ID: 25823684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-TNF-α therapy improves insulin sensitivity in non-diabetic patients with psoriasis: a 6-month prospective study.
    Pina T; Armesto S; Lopez-Mejias R; Genre F; Ubilla B; Gonzalez-Lopez MA; Gonzalez-Vela MC; Corrales A; Blanco R; Garcia-Unzueta MT; Hernandez JL; Llorca J; Gonzalez-Gay MA
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1325-30. PubMed ID: 25353352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetric dimethylarginine but not osteoprotegerin correlates with disease severity in patients with moderate-to-severe psoriasis undergoing anti-tumor necrosis factor-α therapy.
    Pina T; Genre F; Lopez-Mejias R; Armesto S; Ubilla B; Mijares V; Dierssen-Sotos T; Corrales A; Gonzalez-Lopez MA; Gonzalez-Vela MC; Blanco R; Hernández JL; Llorca J; Gonzalez-Gay MA
    J Dermatol; 2016 Apr; 43(4):389-94. PubMed ID: 26364678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor necrosis factor-alpha therapy improves endothelial function and arterial stiffness in patients with moderate to severe psoriasis: A 6-month prospective study.
    Pina T; Corrales A; Lopez-Mejias R; Armesto S; Gonzalez-Lopez MA; Gómez-Acebo I; Ubilla B; Remuzgo-Martínez S; Gonzalez-Vela MC; Blanco R; Hernández JL; Llorca J; Gonzalez-Gay MA
    J Dermatol; 2016 Nov; 43(11):1267-1272. PubMed ID: 27062420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant sE-Selectin levels reduction after 6 months of anti-TNF-α therapy in non-diabetic patients with moderate-to-severe psoriasis.
    Genre F; Armesto S; Corrales A; López-Mejías R; Remuzgo-Martínez S; Pina T; Ubilla B; Mijares V; Martín-Varillas JL; Rueda-Gotor J; Portilla V; Dierssen-Sotos T; González-López MA; González-Vela MDC; Blanco R; Llorca J; Hernández JL; González-Gay MÁ
    J Dermatolog Treat; 2017 Dec; 28(8):726-730. PubMed ID: 28489469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy comparison of ustekinumab between anti-tumor necrosis factor-α drug-naïve and anti-tumor necrosis factor-α drug-resistant Japanese psoriasis cases.
    Takahashi N; Noda S; Taniguchi T; Adachi M
    Int J Dermatol; 2015 Oct; 54(10):1194-8. PubMed ID: 26016819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinol-binding protein 4 in rheumatoid arthritis-related insulin resistance and β-cell function.
    Ferraz-Amaro I; González-Gay MA; Diaz-González F
    J Rheumatol; 2014 Apr; 41(4):658-65. PubMed ID: 24532832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of serum levels of retinol-binding protein 4 with male sex but not with insulin resistance in obese patients.
    Ulgen F; Herder C; Kühn MC; Willenberg HS; Schott M; Scherbaum WA; Schinner S
    Arch Physiol Biochem; 2010 May; 116(2):57-62. PubMed ID: 20222849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of adipocytokines in psoriasis patients receiving tumor necrosis factor-α inhibitors: results of a retrospective analysis.
    Campanati A; Ganzetti G; Giuliodori K; Marra M; Bonfigli A; Testa R; Offidani A
    Int J Dermatol; 2015 Jul; 54(7):839-45. PubMed ID: 25877149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti-tumour necrosis factor agents: subanalysis of BELIEVE.
    Ortonne JP; Chimenti S; Reich K; Gniadecki R; Sprøgel P; Unnebrink K; Kupper H; Goldblum O; Thaçi D
    J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1012-20. PubMed ID: 21214631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with TNF-α inhibitor rectifies M1 macrophage polarization from blood CD14+ monocytes in patients with psoriasis independent of STAT1 and IRF-1 activation.
    Lin SH; Chuang HY; Ho JC; Lee CH; Hsiao CC
    J Dermatol Sci; 2018 Sep; 91(3):276-284. PubMed ID: 29914850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children.
    Aeberli I; Biebinger R; Lehmann R; L'allemand D; Spinas GA; Zimmermann MB
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4359-65. PubMed ID: 17726085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass.
    Gómez-Ambrosi J; Rodríguez A; Catalán V; Ramírez B; Silva C; Rotellar F; Gil MJ; Salvador J; Frühbeck G
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):208-15. PubMed ID: 18081728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between retinol-binding protein 4 levels, insulin resistance, androgen hormones and polycystic ovary syndrome.
    Mellati AA; Sharifi F; Sajadinejad M; Sohrabi D; Mazloomzadeh S
    Scand J Clin Lab Invest; 2012 Feb; 72(1):39-44. PubMed ID: 22023042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic blockade of TNF-α does not improve insulin resistance in humans.
    Ferraz-Amaro I; Arce-Franco M; Muñiz J; López-Fernández J; Hernández-Hernández V; Franco A; Quevedo J; Martínez-Martín J; Díaz-González F
    Horm Metab Res; 2011 Oct; 43(11):801-8. PubMed ID: 22009376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome?
    Olszanecka-Glinianowicz M; Madej P; Zdun D; Bożentowicz-Wikarek M; Sikora J; Chudek J; Skałba P
    Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):55-61. PubMed ID: 22397743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of adalimumab treatment on cardiovascular risk biomarkers in psoriasis: Results of a pilot study.
    Gkalpakiotis S; Arenbergerova M; Gkalpakioti P; Potockova J; Arenberger P; Kraml P
    J Dermatol; 2017 Apr; 44(4):363-369. PubMed ID: 27774694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of topical treatment and psoriasis severity on serum retinol-binding protein-4 levels.
    Baran A; Swiderska M; Flisiak I
    J Dermatolog Treat; 2016; 27(2):114-9. PubMed ID: 26293108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of adalimumab in the treatment of psoriasis: a retrospective study of 15 patients in daily practice.
    Sola-Ortigosa J; Sánchez-Regaña M; Umbert-Millet P
    J Dermatolog Treat; 2012 Jun; 23(3):203-7. PubMed ID: 21787203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.